Search for content, post, videos

Mediracer releases measuring device for monitoring nervous system symptoms in diabetics

Oulu-based company Mediracer has released a measuring device to monitor the progress of degenerative nerve disease.

According to the company, the device’s access to trial use in Japan will be confirmed in July, and thereafter it will also be taken into trial use in some Finnish hospital units.

“After the results of Finnish and Japanese trials, the company will strive for international growth in other regions, too,” says Chief Business Development Officer Yoko Keränen from Mediracer in a press release.

The NCS device’s new DPN feature was achieved by replacing a glued surface electrode with a new stimulation electrode equipped with metal contact heads. This enables nerve conduction measures easier on nerves deeper beneath the skin.

Mediracer Oy manufactures and sells examination technology for the field of clinical neurophysiology. The company was previously known as EMG Technologies Oy, which was a spin-off company of EMG Laboratoriot Oy established in the 1980s. Its founders and owners Veijo Lesonen and Uolevi Tolonen developed the original idea for the product. Nowadays, Mediracer Oy is a part of the Oulu-based Head group which owns several companies both in Oulu and worldwide.


Source: Mediracer